Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVOLVE Short DAPT
NCT02605447Phase 4Completed
- Sponsor
- Boston Scientific Corporation
- Start
- Feb 2016
- Primary completion
- Jul 2019
- Countries
- 7
01
Overview
Phase 4, open-label, single-arm trial in coronary artery disease (CAD), sponsored by Boston Scientific Corporation. Primary endpoints: Number of Participants Who Experienced Death or Myocardial Infarction (MI) and Number of Participants Who Experienced Stent Thrombosis (ST). Started Feb 2016; status: completed.
02
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02605447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02605447.